Cosmos magazine September 10, 2018
Synthetic biology was recognised as a priority area in the 2016 National Research Infrastructure Roadmap. In 2015 the synthetic biology component market (DNA parts) was worth $US5.5 billion – by 2020, it will approach $US40 billion. Those figures don’t count sales revenue from synthetic biology products. Road-maps and associated development structures have been developed through public agencies in many advanced economies, including the US , UK , EU , China , Singapore and Finland … read more.
Clinical trials using immune cells engineered through synthetic biology have been shown to push some patients into remission from blood cancer. Credit: SHUTTERSTOCK